Champions Oncology reports record Q3 revenue $17.0M, net income $4.5M, first data licensing deal up to $8M

CHAMPIONS ONCOLOGY, INC.

2025-Q3 EPS reported $0.46 vs consensus -$0.01 ▲ beat (+4609.8%)

Revenue up 42% YoY to $17.0M; net income of $4.5M vs loss of $2.6M in prior year quarter.
Adjusted EBITDA $5.2M; gross margin improved to 61% from prior 35% on cost reductions.
Signed first major data licensing agreement worth up to $8.0M; hired Matt Newman as EVP/GM for data platform.
Year-to-date revenue $44.6M (+23% YoY); net income $6.5M vs loss of $7.1M in prior nine months.
No debt; cash $3.2M; expects quarterly revenue fluctuations but positioned for sustained profitability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.